BiomX Inc. — Director's Dealing 2022

Feb 14, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2021-12-31

Reporting Person: Ugwumba Chidozie (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3637846	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants to purchase Common Stock	$5	2027-01-28	Common Stock (1875000)		Indirect

Footnotes

F1: The shares are directly held by SymBiosis, LLC. Previously, the beneficial owner of these shares was Thomas Layton Walton, by virtue of his sole voting power and dispositive power through SymBiosis, LLC. Although SymBiosis, LLC continues to hold these shares directly and Thomas Layton Walton continues to hold his pecuniary interest in these shares, the reporting person now exercises sole voting power and dispositive power through SymBiosis, LLC through a transition of that power to the reporting person (and not through a sale or other transfer of these shares).

F2: These shares beneficially owned by the reporting person include (i) 1,137,846 shares of common stock already owned by SymBiosis, LLC prior to July 28, 2021, (ii) 2,500,000 shares of common stock owned by SymBiosis, LLC that were purchased in the registered direct offering by BiomX Inc. that closed on July 28, 2021 and (iii) warrants (to purchase 1,875,000 shares of common stock) owned by SymBiosis, LLC that were purchased in the registered direct offering by BiomX Inc. that closed on July 28, 2021.